Login

AMI Organics Ltd.

₹2227.45

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

AMI Organics Ltd.

₹2227.45

₹2227.45

91.5 (4.28%) - 8 Apr 2025 04:26 PM

About Company

Ami Organics Limited is a research and development (R&D) driven manufacturer of specialty chemicals with varied end usage, focused towards the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates) for regulated and generic active pharmaceutical ingredients (APIs) and New Chemical Entities (NCE) and key starting material for agrochemical and fine chemicals, especially from its recent acquisition of the business of Gujarat Organics (GOL) (Acquisition). The company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban.

Market Cap. ₹8,743 Cr.
52 Week - High/Low ₹2,644/1,008
P/E Ratio 64.92
P/B Ratio 12.95
Enterprise Value ₹8,840 Cr.
ROE % 6.94
RSI Value 82.38
EMA 50 2501.27
EMA 200 2520.83
Net Profit 44 Cr.
Net Profit 3year growth -19.1 Cr.
Net Profit 3 year (back) 54 Cr.
Debt to Equity 0.3 %
EPS Growth TTM 209.79 %
Current Ratio 1.76 %
100 Day SMA 2,222 Rs.
200 Day SMA 1,857 Rs.
21 Day SMA 2,360 Rs.
50 Day SMA 2,321 Rs.
Book Value 165 Rs.
EV/EBITDA Ratio 44
QoQ EPS Growth 20 %
QoQ Operating Profit Growth 38 %
QoQ Sales Growth 11 %
Sales Latest Quarter 271 Cr.
YoY Sales Growth 68 %
Market Cap. ₹8,743 Cr.
52 Week - High/Low ₹2,644/1,008
P/E Ratio 68.33
P/B Ratio 12.97
Enterprise Value ₹8,818 Cr.
ROE % 7.7
RSI Value 82.38
EMA 50 2501.27
EMA 200 2520.83
Net Profit 43 Cr.
Net Profit 3year growth 42.35 Cr.
Net Profit 3 year (back) 54 Cr.
Debt to Equity 0.32 %
EPS Growth TTM 131.9 %
Current Ratio 1.74 %
100 Day SMA 2,222 Rs.
200 Day SMA 1,857 Rs.
21 Day SMA 2,360 Rs.
50 Day SMA 2,321 Rs.
Book Value 165 Rs.
EV/EBITDA Ratio 44
QoQ EPS Growth 20 %
QoQ Operating Profit Growth 40 %
QoQ Sales Growth 11 %
Sales Latest Quarter 275 Cr.
YoY Sales Growth 65 %
Add Parameters

Growth

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Yearly

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.